Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed
Forecasted Federal grant Posted
- Opportunity number
- FOR-FD-25-009
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Applications expected due
- Not on record
- Award size
- $2,000,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Categories
-
- Consumer Protection
- Food and Nutrition
- Agriculture
- Eligible applicants
-
- Unrestricted
- 501(c)(3) Nonprofits
- State Governments
- Tribal Organizations (Not Federally Recognized)
- Tribal Governments (Federally Recognized)
- County Governments
- Non-501(c)(3) Nonprofits
- Public or Indian Housing Auth.
- Special District Governments
- Higher Education Inst. (Private)
- Small Businesses
- City/Township Governments
- Higher Education Inst. (Public)
- For Profit Organizations
- Independent School Districts
- Points of contact
-
- Terrin Brown terrin.brown@fda.hhs.gov (240) 402-7610
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Food and Drug Administration is soliciting applications for cooperative agreements to support clinical trials and research activities related to analgesics, anesthetics, and addiction, with no stated application deadline. Applicants span an unrestricted range of entity types, including for-profit organizations, higher education institutions, nonprofits, state and tribal governments, and small businesses. The program seeks evidence-based plans that advance appropriate prescribing of drug products for analgesia, anesthesia, and substance use disorders, with specific research needs including function as a clinical trial endpoint in chronic pain patients, outcome measures for stimulant use disorder trials, active-control assessment in opioid clinical trials, neurodevelopmental outcome assessment in pediatric patients exposed to anesthesia and opioids, and a living systematic review of anesthetic neurotoxicity in preclinical studies. Multiple awards may be made. No cost share or matching requirement is stated. The award ceiling, floor, and expected number of awards are not specified. Work encompasses research, development, dissemination, implementation, and evaluation across anesthesia, addiction medicine, and pain medicine. This opportunity is funded under CFDA 93.103 (Food and Drug Administration Research), which has obligated $4.17 billion across 3,008 grants with an additional $220 million in non-federal cost-share contribution, predominantly through cooperative agreements (58 percent of awards). The program was posted August 14, 2024.
Forecast synopsis
To develop, disseminate, implement, and evaluate research needed in Anesthesia, Addiction Medicine and Pain Medicine in various fields of research. Specifically, research is needed in the following fields: function as a clinical trial endpoint and measurement of function in patients with chronic pain, outcome measures for clinical trials in stimulant use disorders, assessment of opioid clinical trials with active control in addition to placebo, neurodevelopmental outcome assessment of vulnerable pediatric patients exposed to anesthesia and opioid, and a living systematic review of pre-clinical studies of anesthetic neurotoxicity. Multiple awards may be considered. Applicants must propose a comprehensive evidence-based plan that advances appropriate prescribing of drug products intended for analgesia, anesthesia, and substance use disorders.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity